BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	269.5	278.77	255.44	211.67	421.69	28.95
Short-Term Investments	113.94	39.01	147.39	1,498	848.82	502.2
Cash & Short-Term Investments	1,438	317.78	402.83	1,710	1,271	531.15
Cash Growth	165.73%	-21.11%	-76.44%	34.58%	139.20%	11.42%
Accounts Receivable	351.28	204.61	93.81	52.71	202.49	49.2
Other Receivables	-	49.33	49.64	-	-	-
Receivables	351.28	253.94	143.45	67.93	230.01	70.49
Inventory	1,836	893.81	852.24	406.55	356.16	236.35
Prepaid Expenses	-	5.88	2.28	-	-	-
Other Current Assets	283.44	205.26	190.5	110.93	98.97	74.17
Total Current Assets	3,910	1,677	1,591	2,295	1,956	912.16
Property, Plant & Equipment	4,246	4,175	4,070	2,135	1,034	117.45
Other Intangible Assets	4.55	0.55	1.11	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	-	13.56
Other Long-Term Assets	7.84	7.83	4.83	4.83	4.83	4.55
Total Assets	8,168	5,860	5,667	4,435	2,995	1,048
Accounts Payable	1,106	281.74	225.38	394.28	401.74	201.63
Accrued Expenses	35.73	253.41	144.7	13.82	6.74	0.04
Short-Term Debt	1.05	328.7	473.39	149.35	-	-
Current Portion of Long-Term Debt	324.64	292.72	356.88	57.65	16.32	1.75
Current Unearned Revenue	147.14	150.87	135.59	99.86	41.6	56.68
Other Current Liabilities	-	121.15	67.02	-	-	-
Total Current Liabilities	1,615	1,429	1,403	714.96	466.4	260.09
Long-Term Debt	1,525	1,591	1,772	1,537	873.06	4.98
Long-Term Unearned Revenue	345.56	432.6	503.73	331.33	172.67	0.27
Long-Term Deferred Tax Liabilities	147.78	48.31	13.51	26.55	15.99	-
Total Liabilities	3,633	3,500	3,693	2,610	1,528	265.34
Common Stock	265	190	190	190	190	190
Retained Earnings	2,490	2,170	1,784	1,502	1,200	592.37
Comprehensive Income & Other	-	-	-	132.7	76.27	-
Shareholders' Equity	4,535	2,360	1,974	1,825	1,467	782.37
Total Liabilities & Equity	8,168	5,860	5,667	4,435	2,995	1,048
Total Debt	1,850	2,212	2,603	1,744	889.38	6.73
Net Cash (Debt)	-411.99	-1,894	-2,200	-34.26	381.13	524.42
Net Cash Growth	-	-	-	-	-27.32%	14.87%
Net Cash Per Share	-5.52	-29.91	-34.74	-0.54	6.02	8.28
Filing Date Shares Outstanding	88.33	63.33	63.33	63.33	63.33	63.33
Total Common Shares Outstanding	88.33	63.33	63.33	63.33	63.33	63.33
Working Capital	2,295	248.08	188.34	1,580	1,489	652.07
Book Value Per Share	51.34	37.26	31.17	28.82	23.16	12.35
Tangible Book Value	4,531	2,359	1,973	1,825	1,467	782.37
Tangible Book Value Per Share	51.29	37.25	31.15	28.82	23.16	12.35
Land	-	25.36	25.36	-	-	-
Buildings	-	236.06	214.16	-	-	-
Machinery	-	1,191	708.94	-	-	-
Construction In Progress	30.62	3,516	3,884	-	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.